Results 131 to 140 of about 8,326 (241)

Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy‐induced nausea and vomiting [PDF]

open access: bronze, 2003
Sant P. Chawla   +10 more
openalex   +1 more source

Aprepitant use during chemotherapy and association with survival in women with early breast cancer. [PDF]

open access: yesJ Natl Cancer Inst
Botteri E   +10 more
europepmc   +1 more source

Mechanism Underlying Conflicting Drug-Drug Interaction Between Aprepitant and Voriconazole via Cytochrome P450 3A4-Mediated Metabolism

open access: diamond
Masako Ishida   +7 more
openalex   +2 more sources

Efficacy of Aprepitant in Patients with Advanced or Recurrent Lung Cancer Receiving Moderately Emetogenic Chemotherapy

open access: gold, 2012
Junji Uchino   +11 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy